Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Cost of Revenue (2018 - 2025)

Historic Cost of Revenue for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $14.4 million.

  • Dna X's Cost of Revenue rose 3343.84% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.3 million, marking a year-over-year increase of 1626.65%. This contributed to the annual value of $48.4 million for FY2024, which is 3489.53% down from last year.
  • As of Q3 2025, Dna X's Cost of Revenue stood at $14.4 million, which was up 3343.84% from $10.3 million recorded in Q2 2025.
  • Dna X's Cost of Revenue's 5-year high stood at $22.4 million during Q2 2023, with a 5-year trough of $8.3 million in Q4 2023.
  • Moreover, its 5-year median value for Cost of Revenue was $12.7 million (2021), whereas its average is $13.8 million.
  • In the last 5 years, Dna X's Cost of Revenue skyrocketed by 14603.65% in 2023 and then tumbled by 6185.91% in 2024.
  • Over the past 5 years, Dna X's Cost of Revenue (Quarter) stood at $16.4 million in 2021, then grew by 22.95% to $20.2 million in 2022, then plummeted by 58.83% to $8.3 million in 2023, then surged by 82.52% to $15.2 million in 2024, then dropped by 5.07% to $14.4 million in 2025.
  • Its last three reported values are $14.4 million in Q3 2025, $10.3 million for Q2 2025, and $8.4 million during Q1 2025.